Effectiveness of herpes zoster vaccination in an older United Kingdom population

BACKGROUND: Vaccination against herpes zoster was introduced in the United Kingdom in 2013 for individuals aged 70 years, with a phased catch-up campaign for 71–79 year olds. Vaccine introduction has resulted in a marked fall in incident herpes zoster and in post-herpetic neuralgia (PHN), but formal...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vaccine
Egile Nagusiak: Walker, Jemma L., Andrews, Nick J., Amirthalingam, Gayatri, Forbes, Harriet, Langan, Sinead M., Thomas, Sara L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier Science 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5899761/
https://ncbi.nlm.nih.gov/pubmed/29555217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.02.021
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak